Stock Market News

Illumina to divest cancer test maker Grail

12/17/2023
Less than a minute

2023.12.17 15:36


© Reuters. FILE PHOTO: A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake/File Photo

(Reuters) – Illumina (NASDAQ:) said on Sunday that it would divest cancer diagnostic test maker Grail.

Source link

12/17/2023
Less than a minute

Related Articles

Simon Property’s $8.6 Billion Bid to Buy Kohl’s Seen as an ‘Aggressive’ Move

Simon Property’s $8.6 Billion Bid to Buy Kohl’s Seen as an ‘Aggressive’ Move

04/26/2022
Skydance Media reaches new deal with Shari Redstone’s National Amusements, WSJ reports

Skydance Media reaches new deal with Shari Redstone’s National Amusements, WSJ reports

07/02/2024
Wall Street Opens Sharply Lower on Fresh Inflation, Growth Fears

Wall Street Opens Sharply Lower on Fresh Inflation, Growth Fears

08/22/2022
Robust earnings support European shares; eyes on BoE rate decision

Robust earnings support European shares; eyes on BoE rate decision

08/04/2022
Back to top button